Zentalis Pharmaceuticals, Inc.’s ZNTL share price has surged by 31.29%, which has investors questioning if this is right time to sell.

Nonbloody vaginal discharge can also be a manifestation of endometrial carcinoma and occurs in approximately ... In this study, the high likelihood ratio for a positive test result (4.5) and ...

Equities research analysts at Wedbush boosted their FY2024 EPS estimates for shares of Zentalis Pharmaceuticals in a research note issued to investors on Wednesday, January 29th. Wedbush analyst R.

Zentalis Pharmaceuticals (NASDAQ:ZNTL – Free Report) had its price target lowered by HC Wainwright from $20.00 to $10.00 in a research report released on Wednesday,Benzinga reports. The firm currently ...

Human papillomavirus (HPV) is necessary for the development of cervical carcinoma, and incorporation of molecular testing for HPV in screening and patient management has been proposed. Sufficient ...

The results showed that CasR expression was negatively correlated with the Ki-67 index as well as the grade of malignancy in LUAD ... moderate (2+); and 9–12, high (3+). To validate the possible ...

The US Food and Drug Administration (FDA) has granted breakthrough device designation for Acrivon Therapeutics’ ACR-368 ...

Bleacher Report’s Zachary D Rymer gave the signings an A grade. Under his system ... to have a better year because he had an overly high batting average on balls in play (BABIP), which can ...

A new drug delivery system shows promise for treating a rare, aggressive form of cancer affecting pregnant women and new ...

A new research paper was published in Oncoscience's Volume 12 on January 20, 2025, titled "Maternal, delivery and neonatal outcomes in women with cervical cancer. A study of a population database." ...